Genotype Guided Antiplatelet Therapy
Showing 1 - 25 of >10,000
Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)
Not yet recruiting
- Ischemic Stroke
- Transient Ischemic Attack
- Genetic testing
-
Singapore, SingaporeSingapore General Hospital
Mar 9, 2023
Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)
Recruiting
- Angina, Stable
- +3 more
- CYP2C19 genotype testing
-
Beijing, Beijing, China
- +11 more
Nov 4, 2021
MYOCARDIAL INFARCTION Trial in Paris (single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by
Not yet recruiting
- MYOCARDIAL INFARCTION
- single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.
-
Paris, IDF, FranceHopital Pitié Salpetrière
Jan 10, 2023
Intracranial Aneurysm Trial in Beijing (Adjustment of Antiplatelet Drugs)
Not yet recruiting
- Intracranial Aneurysm
- Adjustment of Antiplatelet Drugs
-
Beijing, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital.
Apr 21, 2023
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease Trial in Bern (Algorithm-guided
Not yet recruiting
- Percutaneous Coronary Intervention
- +2 more
- Algorithm-guided DAPT duration
- Standard-of-care DAPT duration
-
Bern, SwitzerlandBern University Hospital
Feb 16, 2023
Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)
Not yet recruiting
- Peripheral T Cell Lymphoma
- CHOP+selinexor+5-Azacitidine
- +2 more
- (no location specified)
Dec 29, 2022
Personalized Antiplatelet Therapy in CAD Patients
Completed
- Coronary Artery Disease
- (no location specified)
Dec 14, 2021
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Gainesville (DNA sample collection)
Recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- DNA sample collection
-
Gainesville, FloridaUniversity of Florida
Nov 16, 2023
Non ST Segment Elevation Acute Coronary Syndrome Trial in Amsterdam (Prasugrel 10mg, Ticagrelor 90mg)
Active, not recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- Prasugrel 10mg
- Ticagrelor 90mg
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Mar 21, 2022
Peripheral Arterial Disease Trial in Netherlands (Direct CYP2C19 genotyping, CYP2C19 genotyping at the end of the study, Poor
Recruiting
- Peripheral Arterial Disease
- Direct CYP2C19 genotyping
- +4 more
-
Apeldoorn, Netherlands
- +10 more
Apr 19, 2022
Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)
Recruiting
- Acute Coronary Syndrome
- CYP2C19 Polymorphism
-
Nieuwegein, Utrecht, NetherlandsSt. Antonius Hospital
Jun 27, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +
Not yet recruiting
- Coronary Artery Disease
- +2 more
- Aspirin + Clopidogrel + Rivaroxaban
- Aspirin + Clopidogrel
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences, Fuwai Hospital
Dec 5, 2022
Coronary Artery Disease, Smoking Cessation Trial in Saint Louis (other, drug, behavioral)
Active, not recruiting
- Coronary Artery Disease
- Smoking Cessation
- genotype-guided therapy
- +2 more
-
Saint Louis, MissouriBarnes Hospital
Oct 28, 2021
ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy Trial in Dordrecht, Rotterdam (Prasugrel based short DAPT,
Recruiting
- ST Elevated Myocardial Infarction
- Dual Antiplatelet Therapy
- Prasugrel based short DAPT
- +3 more
-
Dordrecht, Netherlands
- +2 more
Aug 5, 2022
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)
Active, not recruiting
- Bleeding Complications
- Clopidogrel
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 31, 2022
Coronary Artery Disease Trial in Nanjing (AntiPlatelet therapy, Percutaneous coronary intervention)
Recruiting
- Coronary Artery Disease
- AntiPlatelet therapy
- Percutaneous coronary intervention
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Nov 4, 2021
Thrombosis, Stent Thrombosis, Bleeding Trial in Edinburg (Cipherome Lighthouse Pilot)
Recruiting
- Thrombosis
- +4 more
- Cipherome Lighthouse Pilot
-
Edinburg, Texas
- +1 more
Jul 18, 2022
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- (no location specified)
Oct 22, 2023
EROSION II: OCT Guided PPCI in STEMI
Active, not recruiting
- ST-segment Elevation Myocardial Infarction
- dual antiplatelet therapy (aspirin + ticagrelor or aspirin + clopidogrel)
-
Beijing, Beijing, China
- +15 more
Jun 23, 2022
Depression, Acute Pain, Chronic Pain Trial in United States (Pharmacogenetic testing, Clinical decisions support)
Recruiting
- Depression
- +2 more
- Pharmacogenetic testing
- Clinical decisions support
-
Wilmington, Delaware
- +12 more
Jan 6, 2023
Warfarin Dose Prescription in Admixed Caribbean Hispanics
Completed
- Atrial Fibrillation
- +4 more
- Genotype-guided
- Standard-of-Care
-
Miami, Florida
- +2 more
May 17, 2022
Coronary Artery Disease, Acute Coronary Syndrome, Stenosis Trial in Worldwide (Clopidogrel, Ticagrelor)
Completed
- Coronary Artery Disease
- +2 more
-
Scottsdale, Arizona
- +40 more
Oct 11, 2021
Chronic Pain Trial in United States (Pharmacogenetic testing, Clinical decisions support)
Recruiting
- Chronic Pain
- Pharmacogenetic testing
- Clinical decisions support
-
Gainesville, Florida
- +9 more
Jul 21, 2023